Toshimitsu Matsui

Toshimitsu Matsui

Auto-generated profile, based on publicly available information

Toshimitsu Matsui

Department of Hematology, Nishiwaki Municipal Hospital, Nishiwaki, Japan

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 1990 in Neuron
Verified
Journal Article
Closed access
RMRandall D. McKinnon
Randall D. McKinnon
TMToshimitsu Matsui
Toshimitsu Matsui
MDMonique Dubois-Dalcq
Monique Dubois-Dalcq
SAStuart A. Aaronsont
Stuart A. Aaronsont

10 February 1989 in Science
Verified
Journal Article
Open access
PDF file
TMToshimitsu Matsui
Toshimitsu Matsui
MHMohammad Heidaran
Mohammad Heidaran
TMToru Miki
Toru Miki
NPNicholas Popescu
Nicholas Popescu
WRWilliam La Rochelle
William La Rochelle
SAStuart Aaronson
Stuart Aaronson
A genomic sequence and cloned complementary DNA has been identified for a novel receptor-like gene of the PDGF receptor/CSF1 receptor subfamily (platelet-derived growth factor receptor/colony-stimulating factor type 1 receptor). The gene recognized a 6.4-kilobase transcript that was coexpressed in normal human tissues with the 5.3-kilobase PDGF receptor messenger RNA. Introduction of complementary DNA of the novel gene into COS-1 cells led to expression of proteins that were specifically detected with antiserum directed against a predicted peptide. When the new gene was transfected into COS-1 cells, a characteristic pattern of binding of the PDGF isoforms was observed, which was different from the pattern observed with the known PDGF receptor. Tyrosine phosphorylation of the receptor in response to the PDGF isoforms was also different from the known receptor. The new PDGF receptor gene was localized to chromosome 4q11-4q12. The existence of genes encoding two PDGF receptors that interact in a distinct manner with three different PDGF isoforms likely confers considerable regulatory flexibility in the functional responses to PDGF.

15 October 1996 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ANA Nagata
A Nagata
MIM Ito
M Ito
NIN Iwata
N Iwata
JKJ Kuno
J Kuno
HTH Takano
H Takano
TNT Noda
T Noda
Many peptide hormone and neurotransmitter receptors belonging to the seven membrane-spanning G protein-coupled receptor family have been shown to transmit ligand-dependent mitogenic signals in vitro. However, the physiological roles of the mitogenic activity through G protein-coupled receptors in vivo remain to be elucidated. Here we have generated G protein-coupled cholecystokinin (CCK)-B/gastrin receptor deficient-mice by gene targeting. The homozygous mice showed a remarkable atrophy of the gastric mucosa macroscopically, even in the presence of severe hypergastrinemia. The atrophy was due to a decrease in parietal cells and chromogranin A-positive enterochromaffin-like cells expressing the H+,K(+)-ATPase and histidine decarboxylase genes, respectively. Oral administration of a proton pump inhibitor, omeprazole, which induced hypertrophy of the gastric mucosa with hypergastrinemia in wild-type littermates, did not eliminate the gastric atrophy of the homozygotes. These results clearly demonstrated that the G protein-coupled CCK-B/gastrin receptor is essential for the physiological as well as pathological proliferation of gastric mucosal cells in vivo.

1 June 2013 in Cell Stem Cell
Verified
Journal Article
Closed access
NANoboru Asada
Noboru Asada
YKYoshio Katayama
Yoshio Katayama
MSMari Sato
Mari Sato
KMKentaro Minagawa
Kentaro Minagawa
KWKanako Wakahashi
Kanako Wakahashi
MTMitsune Tanimoto
Mitsune Tanimoto

1 November 2013 in Cell Metabolism
Verified
Journal Article
Closed access
MSMari Sato
Mari Sato
NANoboru Asada
Noboru Asada
YKYuko Kawano
Yuko Kawano
KWKanako Wakahashi
Kanako Wakahashi
KMKentaro Minagawa
Kentaro Minagawa
YKYoshio Katayama
Yoshio Katayama

15 June 1991 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
RTR Takahashi
R Takahashi
THT Hashimoto
T Hashimoto
HXH J Xu
H J Xu
SHS X Hu
S X Hu
TMT Matsui
T Matsui
WBW F Benedict
W F Benedict
The product of the human retinoblastoma gene (RB) is a nuclear phosphoprotein that is thought to function as a tumor suppressor. Mutations of RB frequently occur in human bladder carcinoma. To investigate the significance of the functional loss of this gene in bladder cancer, an RB expression plasmid (pBARB) under control of the human beta-actin promoter was transfected into the bladder carcinoma cell line HTB9, which lacks RB expression. Marker-selected transfectants that expressed RB protein were identified by immunoblotting and immunohistochemical staining. In selected clones, stable RB expression has persisted over 1 yr under standard culture conditions with 10% serum. However, RB expression caused major alterations of HTB9 growth properties both in vitro and in vivo. RB+ transfectants lacked the ability to form colonies in semi-solid medium, and their growth rate was significantly decreased in 3% serum. In addition, the tumorigenicity of these transfectants was markedly decreased. Tumors that formed in nude mice were much smaller and had a longer latency period but were indistinguishable microscopically from those produced by parental cells. Slower growing tumors were RB+, as measured by nuclear staining of their RB protein and by a normal RB protein pattern on immunoblots. These findings support the concept that the RB gene acts as both a growth and tumor suppressor in bladder cancer cells.